$1.02
-0.045-4.23%
最終更新: Oct 8, 7:57 PM
$1.02
-0.0465-4.37%
Benzinga
Benzinga
Benzinga
金曜日, 10 09
Benzinga
© 2026 Benzinga | All Rights Reserved
PDS Biotechnology (PDSB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.13 | $-0.14 | $-0.20 | $-0.20 |
| Actual | $-0.18 | $-0.13 | $-0.14 | $-0.19 |
| Surprise | -38.5% | +7.14% | +30.0% | +5.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.11 | $-0.09 |
| Revenue | ||
| Consensus | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.18 | $-0.13 | -38.5 % |
| Q1 | May 13, 2026 | $-0.13 | $-0.14 | 7.14 % |
| Q4 | Mar 30, 2026 | $-0.14 | $-0.20 | 30.0 % |
| Q3 | Nov 13, 2025 | $-0.19 | $-0.20 | 5.00 % |